Atrás
33
Rango del Día
$0.01
$14.22
Rango de 52 Semanas
$0.01
$14.22
Volumen
1,479
Promedio 50D / 200D
$14.22
/
$14.22
Cierre Anterior
$14.22
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.6 | 0.4 |
| P/B | 1.3 | 2.9 |
| ROE % | -22.8 | 3.8 |
| Net Margin % | -7.3 | 3.9 |
| Rev Growth 5Y % | 9.5 | 10.0 |
| D/E | 5.1 | 0.2 |
Puntos Clave
Revenue grew 9.48% annually over 5 years — modest growth
Earnings declined -130.41% over the past year
Debt/Equity of 5.14 — high leverage
Generating 328.61M in free cash flow
PEG of 0.05 suggests growth is underpriced
Capital efficient — spends only 2.55% of revenue on capex
Crecimiento
Revenue Growth (5Y)
9.48%
Revenue (1Y)8.42%
Earnings (1Y)-130.41%
FCF Growth (3Y)14.42%
Calidad
Return on Equity
-22.82%
ROIC-0.27%
Net Margin-7.31%
Op. Margin-0.68%
Seguridad
Debt / Equity
5.14
Current Ratio0.72
Interest Coverage-0.10
Valoración
P/E Ratio
-5.57
P/B Ratio1.33
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.42% | Revenue Growth (3Y) | 9.73% |
| Earnings Growth (1Y) | -130.41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9.48% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.64B | Net Income (TTM) | -412.07M |
| ROE | -22.82% | ROA | -3.07% |
| Gross Margin | 80.01% | Operating Margin | -0.68% |
| Net Margin | -7.31% | Free Cash Flow (TTM) | 328.61M |
| ROIC | -0.27% | FCF Growth (3Y) | 14.42% |
| Safety | |||
| Debt / Equity | 5.14 | Current Ratio | 0.72 |
| Interest Coverage | -0.10 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.57 | P/B Ratio | 1.33 |
| P/S Ratio | 0.41 | PEG Ratio | 0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.29B | Enterprise Value | 10.63B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 5.64B | 5.20B | 4.68B | 4.30B | 3.92B |
| Net Income | -412.07M | 1.35B | -4.03B | 65.19M | 160.05M |
| EPS (Diluted) | -2.62 | 652.97 | -3116.52 | 47.68 | 117.17 |
| Gross Profit | 4.51B | 655.93M | -91.39M | 277.71M | 459.68M |
| Operating Income | -38.20M | -918.73M | -664.29M | 364.61M | 426.42M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 13.41B | 13.91B | 14.49B | 17.07B | 16.97B |
| Total Liabilities | 11.69B | 12.02B | 16.00B | 14.74B | 13.48B |
| Shareholders' Equity | 1.72B | 1.89B | -1.50B | 2.32B | 3.50B |
| Total Debt | 8.86B | 9.16B | 13.38B | 12.13B | 10.53B |
| Cash & Equivalents | 518.72M | 644.95M | 856.42M | 952.37M | 888.84M |
| Current Assets | 1.88B | 2.37B | 1.91B | 2.42B | 1.86B |
| Current Liabilities | 2.62B | 3.12B | 9.96B | 3.54B | 2.63B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#339 of 616
Actividad Reciente
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026